Our Team

Soricimed’s experienced team is committed to the development of targeted therapies for solid tumor cancers.

Management

Robert Bruce

CEO

Read bio

Hidden bio content

Bob Cory

Vice President Business Development & COO

Read bio

Hidden bio content

Dominique Dugourd

Vice President Research & Development

Read bio

Hidden bio content

Helen Macnab-Gunn

Office Administrator

Read bio

Hidden bio content

Sam Magee

Financial Analyst

Read bio

Hidden bio content

Tyler Lute

Senior Scientist

Read bio

Hidden bio content

Jack Stewart

Chief Scientific Officer & Director

Read bio

Hidden bio content

Paul Gunn

President

Read bio

Hidden bio content

Interested in our work?

Join the team

Get in Touch

Our Directors

Vaughn Embro-Pantalony

Chairman

Read bio

Vaughn Embro-Pantalony

Chairman

  • Current Board Member and Former CEO of Microbix Biosystems Inc. (TSX:MBX)
  • Former V.P. Finance and Chief Financial Officier of Novopharm Limited;
  • V.P. Information Technology & Chief Information Officer of Bayer Inc

Marc Rubin

Director

Read bio

Marc Rubin

Director

  • Currently Executive Chairman of Titan Pharmaceuticals, Inc. (NASDAQ:TTNP); Chairman of Galectin Therapeutics (NASDAQ:GALT); Board Member of Curis Inc. (NASDAQ:CRIS)
  • Former Head of Global Research and Development for Bayer Schering Pharma
  • Previous executive roles with Schering AG and GlaxoSmithKline

Thomas Reeves

Director

Read bio

Thomas Reeves

Director

  • Current President & CEO of Interface Biologics
  • Former President & COO of Occulogix, Inc. (NASDAQ:RHEO)

Camille Belliveau

Director

Read bio

Camille Belliveau

Director

  • Former public accountant and Executive Director of EPR Canada Group

Susan Hicks

Director

Read bio

Susan Hicks

Director

  • President and CEO of Technology Venture Corporation (TVC)

Paul Gunn

President

Read bio

Hidden bio content

Jack Stewart

Chief Scientific Officer & Director

Read bio

Hidden bio content

Sign up to receive updates from Soricimed

Powered by Innovasium